lOMoAR cPSD| 57394295
, lOMoAR cPSD| 57394295
Contents
Chapter 01: The Nursing Process and Drug Therapy ....................................................................................
4
Chapter 02: Pharmacologic Principles ..........................................................................................................
8
Chapter 03: Lifespan Considerations ...........................................................................................................
14
Chapter 04: Cultural, Legal, and Ethical Considerations ............................................................................ 20
Chapter 05: Medication Errors: Preventing and Responding ..................................................................... 26
Chapter 06: Patient Education and Drug Therapy ...................................................................................... 29
Chapter 07: Over-the-Counter Drugs and Herbal and Dietary Supplements ............................................. 34
Chapter 08: Gene Therapy and Pharmacogenomics ................................................................................... 38
Chapter 09: Photo Atlas of Drug Administration .........................................................................................
41
Chapter 10: Analgesic Drugs ....................................................................................................................... 50
Chapter 11: General and Local Anesthetics ................................................................................................. 57
Chapter 12: Central Nervous System Depressants and Muscle Relaxants ...................................................
61
Chapter 13: Central Nervous System Stimulants and Related Drugs ......................................................... 66
Chapter 14: Antiepileptic Drugs .................................................................................................................. 70
Chapter 15: Antiparkinson Drugs .................................................................................. 76
Chapter 16: Psychotherapeutic Drugs ......................................................................................................... 81
Chapter 17: Substance Use Disorder ........................................................................................................... 88
Chapter 18: Adrenergic Drugs .....................................................................................................................
93
Chapter 19: Adrenergic-Blocking Drugs ..................................................................................................... 98
Chapter 20: Cholinergic Drugs ..................................................................................................................
103
Chapter 21: Cholinergic-Blocking Drugs ....................................................................................................
108
, lOMoAR cPSD| 57394295
Chapter 22: Antihypertensive Drugs ......................................................................................................... 113
Chapter 23: Antianginal Drugs .................................................................................................................. 119
Chapter 24: Heart Failure Drugs ............................................................................................................... 125
Chapter 25: Antidysrhythmic Drugs .......................................................................................................... 131
Chapter 26: Coagulation Modifier Drugs ...................................................................................................
137 Chapter 27: Antilipemic Drugs
................................................................................................................... 143
Chapter 28: Diuretic Drugs
........................................................................................................................148
Chapter 29: Fluids and Electrolytes ...........................................................................................................
154
Chapter 30: Pituitary Drugs .......................................................................................................................
160
Chapter 01: The Nursing Process and Drug Therapy
MULTIPLE CHOICE
1. The nurse is writing a nursing diagnosis for a plan of care for a patient who has been newly
diagnosed with type 2 diabetes. Which statement reflects the correct format for a nursing
diagnosis? a. Anxiety
b. Anxiety related to new drug therapy
c. Anxiety related to anxious feelings about drug therapy, as evidenced by statements
such as “I’m upset about having to test my blood sugars.”
d. Anxiety related to new drug therapy, as evidenced by statements such as “I’m upset about
having to test my blood sugars.”
ANSWERS: D
Formulation of nursing diagnoses is usually a three-step process. “Anxiety” is missing the
“related to” and “as evidenced by” portions of defining characteristics. “Anxiety related to new
drug therapy” is missing the “as evidenced by” portion of defining characteristics. The
statement beginning “Anxiety related to anxious feelings” is incorrect because the “related to”
section is simply a restatement of the problem “anxiety,” not a separate factor related to the
response.
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
TOP: NURSING PROCESS: Nursing DiagNnUosRiSs INGTB.COM
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
2. The patient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nurse was busy
and gave the medication 2 hours after the scheduled dose was due. What type of problem
does this represent?
a. “Right time”
b. “Right dose”
c. “Right route”
d. “Right medication”
, lOMoAR cPSD| 57394295
Contents
Chapter 01: The Nursing Process and Drug Therapy ....................................................................................
4
Chapter 02: Pharmacologic Principles ..........................................................................................................
8
Chapter 03: Lifespan Considerations ...........................................................................................................
14
Chapter 04: Cultural, Legal, and Ethical Considerations ............................................................................ 20
Chapter 05: Medication Errors: Preventing and Responding ..................................................................... 26
Chapter 06: Patient Education and Drug Therapy ...................................................................................... 29
Chapter 07: Over-the-Counter Drugs and Herbal and Dietary Supplements ............................................. 34
Chapter 08: Gene Therapy and Pharmacogenomics ................................................................................... 38
Chapter 09: Photo Atlas of Drug Administration .........................................................................................
41
Chapter 10: Analgesic Drugs ....................................................................................................................... 50
Chapter 11: General and Local Anesthetics ................................................................................................. 57
Chapter 12: Central Nervous System Depressants and Muscle Relaxants ...................................................
61
Chapter 13: Central Nervous System Stimulants and Related Drugs ......................................................... 66
Chapter 14: Antiepileptic Drugs .................................................................................................................. 70
Chapter 15: Antiparkinson Drugs .................................................................................. 76
Chapter 16: Psychotherapeutic Drugs ......................................................................................................... 81
Chapter 17: Substance Use Disorder ........................................................................................................... 88
Chapter 18: Adrenergic Drugs .....................................................................................................................
93
Chapter 19: Adrenergic-Blocking Drugs ..................................................................................................... 98
Chapter 20: Cholinergic Drugs ..................................................................................................................
103
Chapter 21: Cholinergic-Blocking Drugs ....................................................................................................
108
, lOMoAR cPSD| 57394295
Chapter 22: Antihypertensive Drugs ......................................................................................................... 113
Chapter 23: Antianginal Drugs .................................................................................................................. 119
Chapter 24: Heart Failure Drugs ............................................................................................................... 125
Chapter 25: Antidysrhythmic Drugs .......................................................................................................... 131
Chapter 26: Coagulation Modifier Drugs ...................................................................................................
137 Chapter 27: Antilipemic Drugs
................................................................................................................... 143
Chapter 28: Diuretic Drugs
........................................................................................................................148
Chapter 29: Fluids and Electrolytes ...........................................................................................................
154
Chapter 30: Pituitary Drugs .......................................................................................................................
160
Chapter 01: The Nursing Process and Drug Therapy
MULTIPLE CHOICE
1. The nurse is writing a nursing diagnosis for a plan of care for a patient who has been newly
diagnosed with type 2 diabetes. Which statement reflects the correct format for a nursing
diagnosis? a. Anxiety
b. Anxiety related to new drug therapy
c. Anxiety related to anxious feelings about drug therapy, as evidenced by statements
such as “I’m upset about having to test my blood sugars.”
d. Anxiety related to new drug therapy, as evidenced by statements such as “I’m upset about
having to test my blood sugars.”
ANSWERS: D
Formulation of nursing diagnoses is usually a three-step process. “Anxiety” is missing the
“related to” and “as evidenced by” portions of defining characteristics. “Anxiety related to new
drug therapy” is missing the “as evidenced by” portion of defining characteristics. The
statement beginning “Anxiety related to anxious feelings” is incorrect because the “related to”
section is simply a restatement of the problem “anxiety,” not a separate factor related to the
response.
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
TOP: NURSING PROCESS: Nursing DiagNnUosRiSs INGTB.COM
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
2. The patient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nurse was busy
and gave the medication 2 hours after the scheduled dose was due. What type of problem
does this represent?
a. “Right time”
b. “Right dose”
c. “Right route”
d. “Right medication”
